Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Annexin V (human), (recombinant) (FITC conjugate)

 
ALX-209-250-T020 20 tests 120.00 USD
 
ALX-209-250-T100 100 tests 437.00 USD
 
ALX-209-250-T300 300 tests 659.00 USD
Do you need bulk/larger quantities?
 
FITC-labelled recombinant human annexin V shows bright green fluorescence (Ex(max): 488nm; Em(max): 530nm).

Product Specification

MW:~35.8kDa.
 
Source:Produced in E. coli.
 
UniProt ID:P08758
 
Quantity:20 tests/100µl; 100 tests/500µl; 300 tests/1'500µl.
 
Formulation:Liquid. In 50mM TRIS, pH 7.4, containing 100mM sodium chloride, 1% BSA and 0.02% sodium azide.
 
Purity:≥98% (SDS-PAGE, HPLC)
 
Specificity:Binds to phosphatidylserine (PS).
 
Biological Activity:Exhibits anti-phospholipase activity.
 
Applications:Flow Cytometry
 
Application Notes:Detection of apoptotic cells by flow cytometry.
 
Shipping:Shipped on Blue Ice
 
Long Term Storage:+4°C
 
Handling:After opening, prepare aliquots and store at -20°C.
 
Protocol:Flow Cytometry Protocol:
- Prepare binding buffer (10mM Hepes/NaOH, pH 7.4, 140mM NaCl, 2.5mM CaCl2; filtered through 0.2µm pore filter).
- Brief centrifugation of annexin V-FITC before use is recommended
- Wash cells in PBS by gentle shaking or pipetting up and down.
- Resuspend cells in binding buffer; adjust cell density to 2-5x105/ml
- Take 195µl cell suspension and add 5µl annexin V-FITC
- Mix and incubate 10 min. in the dark at room temperature
- Wash cells 1x with PBS and resuspend in 190µl binding buffer
- Add 10µl of 20µg/ml propidium iodide stock solution (end concentration 1µg/ml)
- FACS analysis
 

Product Literature References

Novel Compounds Targeting the Mitochondrial Protein VDAC1 Inhibit Apoptosis and Protect Against Mitochondria Dysfunction: D. Ben-Hail, et al.; J. Biol. Chem. 291, 24986 (2016), Application(s): Flow cytometry using propidium iodide (PI) and annexin V-FITC staining, Abstract; Full Text
VDAC1-interacting anion transport inhibitors inhibit VDAC1 oligomerization and apoptosis: D. Ben-Hail, et al.; Biochim. Biophys. Acta 1863, 1612 (2016), Application(s): Flow cytometry, Abstract;
Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells: C. Amantini, et al.; Oncoscience 2, 395 (2015), Application(s): FACS, Abstract; Full Text
Ca 2+-mediated regulation of VDAC1 expression levels is associated with cell death induction: S. Weisthal, et al.; Biochim. Biophys. Acta 1843, 2270 (2014), Abstract;
Increased growth-inhibitory and cytotoxic activity of arsenic trioxide in Head and Neck carcinoma cells with functional p53 deficiency and resistance to EGFR blockade: M. Boyko-Fabian, et al.; PLoS One 9, e98867 (2014), Abstract; Full Text
4-Nonylphenol triggers apoptosis and affects 17-β-Estradiol receptors in calvarial osteoblasts: M.G. Sabbieti, et al. ; Toxicology 290, 334 (2013), Abstract;
Cytoprotective effects of opioids on irradiated oral epithelial cells: N. Charbaji, et al.; Wound Repair Regen. 21, 883 (2013), Abstract;
Dealcoholated red wine induces autophagic and apoptotic cell death in an osteosarcoma cell line: I. Tedesco, et al.; Food Chem. Toxicol. 60, 377 (2013), Abstract;
Patients affected by metabolic syndrome show decreased levels of circulating platelet derived growth factor (PDGF)-BB: V. Tisato, et al.; Clin. Nutr. 32, 259 (2013), Abstract;
The role of calcium in VDAC1 oligomerization and mitochondria-mediated apoptosis : N. Keinan, et al.; Biochim. Biophys. Acta 1833, 1745 (2013), Abstract;
VDAC1-based peptides: novel pro-apoptotic agents and potential therapeutics for B-cell chronic lymphocytic leukemia: T. Prezma, et al.; Cell Death Dis. 4, e809 (2013), Abstract; Full Text
Inactivation of Bcl-2 through IκB kinase (IKK)-dependent phosphorylation mediates apoptosis upon exposure to 4-hydroxynonenal (HNE): C. Bodur, et al.; J. Cell. Physiol. 227, 3556 (2012), Abstract;
Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition: S. Patntirapong, et al.; J. Oral Pathol. Med. 41, 713 (2012), Abstract;
NF-κB targeting by way of IKK inhibition sensitizes lung cancer cells to adenovirus delivery of TRAIL: C. Aydin, et al.; BMC Cancer 10, 584 (2010), Abstract; Full Text
CD95 engagement releases calcium from intracellular stores of long term activated, apoptosis-prone gammadelta T cells: P. Rovere, et al.; J. Immunol. 156, 4631 (1996), Abstract;
Quantification of apoptotic cells with fluorescein isothiocyanate- labeled annexin V in chinese hamster ovary cell cultures treated with cisplatin: A.W.M. Boersma, et al.; Cytometry 24, 123 (1996), Abstract;
A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V: I. Vermes, et al.; J. Immunol. Meth. 184, 39 (1995), Abstract;
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl: S. Martin, et al.; J. Exp. Med. 182, 1545 (1995), Abstract;
Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro: C.H. Homburg, et al.; Blood 85, 532 (1995), Abstract;
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis: G. Koopman, et al.; Blood 84, 1415 (1994), Abstract;
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages: V.A. Fadok, et al.; J. Immunol. 148, 2207 (1992), Abstract;
Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers: H.A. Andree, et al.; J. Biol. Chem. 265, 4923 (1990), Abstract; Full Text

Related Products

Annexin V (human), (recombinant) (R-PE conjugate) 

Produced in E. coli., ≥89% (SDS-PAGE, HPLC), Flow Cytometry | Print as PDF
 
ALX-209-251-T020 20 tests 120.00 USD
 
ALX-209-251-T100 100 tests 347.00 USD
Do you need bulk/larger quantities?
 

Annexin V (human), (recombinant) (APC conjugate) 

Produced in E. coli., ≥89% (SDS-PAGE, HPLC), Flow Cytometry | Print as PDF
 
ALX-209-252-T020 20 tests 120.00 USD
 
ALX-209-252-T100 100 tests 347.00 USD
Do you need bulk/larger quantities?
 

Annexin V (human), (recombinant) (FITC conjugate) 

Produced in E.coli. , ≥90%, Flow Cytometry | Print as PDF
 
ALX-209-256-T100 100 tests 200.00 USD
 
ALX-209-256-3100 3x100 tests 456.00 USD
Do you need bulk/larger quantities?
 

Annexin V (human), (recombinant) (ATTO 488 conjugate) 

Produced in E. coli., ≥90%, Flow Cytometry, IF | Print as PDF
 
ALX-209-258-T100 100 tests 240.00 USD
Do you need bulk/larger quantities?
 

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Annexin
By biological activity:
Annexin Recombinant protein
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Related Literature

Brochures
Monitor programmed cell death from membrane to nucleus
Monitor programmed cell death from membrane to nucleus
Download as PDF

Technical Posters
Arachidonic Acid Metabolites
Arachidonic Acid Metabolites
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,